Baxter Tagged Articles

Another lawsuit filed in tainted heparin scandal

Posted: December 18, 2008 Pharmaceutical

Another lawsuit has been filed against the Wisconsin-based heparin manufacturer, Scientific Protein Laboratories and one of its major distributors, Baxter International Inc., claiming the companies allowed contaminated batches of heparin to reach hospitals and medical facilities, where it led to

Barton wants answers from FDA about heparin scandal

Posted: December 17, 2008 Pharmaceutical

Rep. Joe Barton, a ranking member of the House Energy and Commerce Committee, appears to be fed up with the FDA’s reluctance to provide details of the tainted heparin scandal that first came into public light earlier this year, according

FDA commissioner announces plans to resign next month

Posted: December 16, 2008 Pharmaceutical

The Associated Press reported today that Food and Drug Administration Commissioner Dr. Andrew von Eschenbach will resign from his post effective Jan. 20, the same day president-elect Barack Obama takes office. Von Eschenbach was appointed by President Bush in 2005

Congressman questions FDA's slow action on heparin seizure

Posted: December 11, 2008 Pharmaceutical

A Texas congressman is questioning why the FDA waited six months to seize lots of contaminated heparin from an Ohio company, according to CNN Money.

Drug company launches Web site to highlight safety measures

Posted: December 9, 2008 Pharmaceutical

The sole provider of heparin in the United States, APP Pharmaceuticals LLC, has launched a Web site as a first step toward improving the safety of the medications it sells in the U.S., according to Reuters. The Web site details

MIT report proves type of contaminant in Chinese heparin

Posted: December 3, 2008 Pharmaceutical

A team of researchers from the Massachusetts Institute of Technology (MIT) has confirmed that over-sulfated chondroitin sulfate was, in fact, the contaminant in heparin that was manufactured in China and triggered serious allergic reactions that caused more than 80 Americans to

Baxter International spent thousands on lobbying efforts

Posted: November 27, 2008 Pharmaceutical

Drug maker Baxter International Inc., shelled out more than $720,000 in the third quarter of the year lobbying on health care issues including government reimbursement for kidney dialysis treatment and increased funding for kidney disease education, according to Forbes/Associated Press.

Scientists on road to modifying, customizing human heparin

Posted: November 26, 2008 Pharmaceutical

Scientists at University of North Carolina at Chapel Hill have learned to modify the human enzyme that produces heparin, which may lead to a more effective synthetic version of the blood thinner, according to Newswise Medical News.

Lawmaker questions FDA investigation of heparin scandal

Posted: November 21, 2008 Pharmaceutical

A Washington lawmaker is raising concerns about the FDA’s handling of the tainted heparin scandal earlier this year, claiming that the agency misrepresented deaths tied to the product and didn’t thoroughly investigate the situation, according to CNN Money.

Time shares story of family affected by heparin contamination

Posted: November 14, 2008 Pharmaceutical

A recent Time magazine story gives us a glimpse into a family affected by the contaminated heparin tragedy: Leroy Hubley’s wife of 48 years, Bonnie, suffered from polycystic kidney disease, a genetic kidney disease in which cysts grow in the